
Linkon Cure
2025 Receiving Stats
2025 Receiving Projections

Available to play in Week 5
Cure (knee) is not on the injury report for Saturday's game against Central Florida.
ANALYSIS
Cure was limited to 12 snaps in Week 3 Arizona, and that's all the action he's seen this season. He should add depth to the tight end position, but he's not likely to play a big role on offense any time soon, limiting his fantasy upside considerably.
Cure was limited to 12 snaps in Week 3 Arizona, and that's all the action he's seen this season. He should add depth to the tight end position, but he's not likely to play a big role on offense any time soon, limiting his fantasy upside considerably.
College Football Stats
Loading CFB Stats...
2025 CFB Game Log
2025
2025 CFB Game Log
Loading Game Log...
Wildcats Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
More Fantasy News

Remains out
Cure (knee) didn't play in the Week 3 game against Arizona and his next chance will be against Central Florida on Sep. 27.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.

DNP against Army
Cure (knee) was held out of Saturday's matchup against Army.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.

Spotted warming up
Cure (knee) was spotted warming up for Kansas State ahead of the Wildcats' clash with Army, per Cole Carmody of 247Sports.com.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.

Close to getting on field
Cure (knee) is close to getting back on a football field for games, Kellis Robinett of The Wichita Eagle reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.

DNP again
Cure (knee) did not play during Kansas State's 38-35 win Saturday against North Dakota.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Subscribe now to instantly reveal our take on this news.